Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N
Department of Endocrinology, Metabolism and Diabetes, Kinki University School of Medicine, Osaka-sayama, Osaka, Japan.
Clin Endocrinol (Oxf). 2006 Jan;64(1):37-45. doi: 10.1111/j.1365-2265.2005.02412.x.
To further analyse the significance and mutual relationship of thyroid function-linked alterations in cortisol metabolism that have been separately and variously reported.
Twenty-four-hour urine samples from 21 patients with hyperthyroidism (Graves' disease), 16 patients with hypothyroidism (Hashimoto's thyroiditis), 21 healthy age- and sex-matched controls for hyperthyroidism, and 16 healthy age- and sex-matched controls for hypothyroidism were evaluated for 6beta-hydroxycortisol (6beta-OHF), tetrahydrocortisol (THF), tetrahydrocortisone (THE), allo-tetrahydrocortisol (allo-THF), urinary free cortisol (UFF), urinary free cortisone (UFE) and 17-hydroxycorticosteroid (17-OHCS).
Urinary 17-OHCS, THE and allo-THF levels increased considerably in hyperthyroid patients compared to the controls, while UFF and THF showed no difference between the two groups. Urinary 6beta-OHF was significantly lower in the hyperthyroid patients than in the controls. Both the urinary allo-THF + THF/THE and the UFF/UFE ratios were significantly lower in the hyperthyroid patients than in the controls, whereas only the former was significantly higher in the hypothyroid patients than in the controls. The urinary allo-THF/THF ratio was significantly higher in the hyperthyroid patients and significantly lower in the hypothyroid patients than in the controls. In an analysis of pooled subjects including all groups (n = 64), free T4 levels correlated negatively (P < 0.0001) with the urinary allo-THF + THF/THE ratio but not with the UFF/UFE ratio. The serum levels of free T4 correlated positively (P < 0.0001) with the urinary allo-THF/THF ratio.
The thyroid hormones seem to affect the total 11beta-HSD activity (allo-THF + THF/THE) more strongly than the renal 11beta-HSD2 activity (UFF/UFE). 5alpha-reductase activity (allo-THF/THF) is also enhanced in hyperthyroidism, while the reduction of urinary 6beta-OHF in hyperthyroidism might be a secondary effect of the altered activity of the total 11beta-HSD and 5alpha-reductase.
进一步分析已分别且多样报道的甲状腺功能相关的皮质醇代谢改变的意义及相互关系。
对21例甲状腺功能亢进症(格雷夫斯病)患者、16例甲状腺功能减退症(桥本甲状腺炎)患者、21例年龄和性别匹配的甲状腺功能亢进症健康对照者以及16例年龄和性别匹配的甲状腺功能减退症健康对照者的24小时尿液样本进行评估,检测6β-羟基皮质醇(6β-OHF)、四氢皮质醇(THF)、四氢可的松(THE)、表-四氢皮质醇(allo-THF)、尿游离皮质醇(UFF)、尿游离可的松(UFE)和17-羟皮质类固醇(17-OHCS)。
与对照组相比,甲状腺功能亢进症患者的尿17-OHCS、THE和allo-THF水平显著升高,而两组间UFF和THF无差异。甲状腺功能亢进症患者的尿6β-OHF显著低于对照组。甲状腺功能亢进症患者的尿allo-THF + THF/THE比值和UFF/UFE比值均显著低于对照组,而仅前者在甲状腺功能减退症患者中显著高于对照组。甲状腺功能亢进症患者的尿allo-THF/THF比值显著高于对照组,甲状腺功能减退症患者则显著低于对照组。在对包括所有组(n = 64)的汇总受试者分析中,游离T4水平与尿allo-THF + THF/THE比值呈负相关(P < 0.0001),但与UFF/UFE比值无关。血清游离T4水平与尿allo-THF/THF比值呈正相关(P < 0.0001)。
甲状腺激素似乎对总的11β-羟类固醇脱氢酶活性(allo-THF + THF/THE)的影响比对肾脏11β-羟类固醇脱氢酶2活性(UFF/UFE)的影响更强。5α-还原酶活性(allo-THF/THF)在甲状腺功能亢进症中也增强,而甲状腺功能亢进症中尿6β-OHF的降低可能是总的11β-羟类固醇脱氢酶和5α-还原酶活性改变的继发效应。